Aug 25
|
Is There An Opportunity With AbbVie Inc.'s (NYSE:ABBV) 42% Undervaluation?
|
Aug 24
|
Top Analyst Reports for Procter & Gamble, AbbVie & Walt Disney
|
Aug 24
|
CVS Health launches new brand Cordavis to target $100 billion biosimilar market
|
Aug 24
|
Can AbbVie (ABBV) Protect Revenues After Humira Patent Loss?
|
Aug 24
|
CVS is launching a genius way to cut costs for its customers
|
Aug 23
|
UPDATE 2-CVS launches unit to market and co-produce biosimilar medicines
|
Aug 22
|
12 Best Cheap Dividend Stocks To Buy Now
|
Aug 22
|
7 Top Dividend Stocks for Income and Stability
|
Aug 21
|
These 3 Large-Cap Pharma Stocks Have Been Red-Hot
|
Jul 19
|
AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know
|
Jul 18
|
12 Best Dividend Stocks Under $25
|
Jul 18
|
The Zacks Analyst Blog Highlights Walmart, AbbVie, Nike, Uber and PayPal
|
Jul 17
|
Top Analyst Reports for Walmart, AbbVie & Nike
|
Jul 17
|
12 Best Dividend Stocks Under $10
|
Jul 17
|
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
|
Jul 16
|
3 Dividend Growth Stocks to Buy and Hold
|
Jul 16
|
7 Spectacular High-Yield Dividend Stocks to Buy in July
|
Jul 13
|
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
|
Jul 13
|
Big Pharma Ramps Up Fight Against Medicare Price Negotiations
|
Jul 13
|
AbbVie (NYSE:ABBV) shareholders have earned a 14% CAGR over the last five years
|